These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 37829257)
21. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation. Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349 [TBL] [Abstract][Full Text] [Related]
22. A Comprehensive Pan-Cancer Analysis Reveals Cyclin-Dependent Kinase Inhibitor 2A Gene as a Potential Diagnostic and Prognostic Biomarker in Colon Adenocarcinoma. Salem A; Ahmed S; Khalfallah M; Hamadan N; ElShikh W; Alfaki M Cureus; 2024 May; 16(5):e60586. PubMed ID: 38894777 [TBL] [Abstract][Full Text] [Related]
23. A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets. Fu X; Ji F; He Q; Qiu X J Immunol Res; 2022; 2022():5826741. PubMed ID: 35791393 [TBL] [Abstract][Full Text] [Related]
24. Rewired functional regulatory networks among miRNA isoforms (isomiRs) from let-7 and miR-10 gene families in cancer. Liang T; Han L; Guo L Comput Struct Biotechnol J; 2020; 18():1238-1248. PubMed ID: 32542110 [TBL] [Abstract][Full Text] [Related]
25. Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker. Wang Y; Liu T; Zhang K; Huang RH; Jiang L Eur J Med Res; 2023 Jul; 28(1):258. PubMed ID: 37501187 [TBL] [Abstract][Full Text] [Related]
26. CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors. Shen J; Gong X; Tan S; Zhang Y; Xia R; Xu S; Wang S; Zhou H; Jiang Y; Zhao T; Zhang Y; Tang H; Wang C Curr Med Chem; 2024 Jun; ():. PubMed ID: 38952160 [TBL] [Abstract][Full Text] [Related]
27. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma. Deng T; Liu Y; Zhuang J; Tang Y; Huo Q Front Oncol; 2022; 12():632042. PubMed ID: 35515103 [TBL] [Abstract][Full Text] [Related]
28. Identification of Zheng R; Zhu HL; Hu BR; Ruan XJ; Cai HJ World J Clin Cases; 2020 Jul; 8(14):2917-2929. PubMed ID: 32775374 [TBL] [Abstract][Full Text] [Related]
29. Good or not good: Role of miR-18a in cancer biology. Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453 [TBL] [Abstract][Full Text] [Related]
30. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors. Ding Q; Li R; Wang Q; Yu L; Zi F Front Oncol; 2023; 13():1049147. PubMed ID: 38053661 [TBL] [Abstract][Full Text] [Related]
31. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation. Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ Front Genet; 2023; 14():1041042. PubMed ID: 36936420 [No Abstract] [Full Text] [Related]
32. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues. Zhang J; Lu T; Lu S; Ma S; Han D; Zhang K; Xu C; Liu S; Gan L; Wu X; Yang F; Wen W; Qin W Comput Struct Biotechnol J; 2023; 21():665-676. PubMed ID: 36659929 [TBL] [Abstract][Full Text] [Related]
33. Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis. Chen Y; Wu Z; Yi X Sci Rep; 2024 Aug; 14(1):19071. PubMed ID: 39154046 [TBL] [Abstract][Full Text] [Related]
34. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker. Yang W; Liu Z; Liu T Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265 [TBL] [Abstract][Full Text] [Related]
35. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
36. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191 [TBL] [Abstract][Full Text] [Related]
37. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types. Guo B; Wang Y; Liu W; Zhang S Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 ( Zhang J; Zheng Z; Zheng J; Xie T; Tian Y; Li R; Wang B; Lin J; Xu A; Huang X; Yuan Y Front Oncol; 2019; 9():342. PubMed ID: 31134149 [TBL] [Abstract][Full Text] [Related]
39. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers. Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y Front Immunol; 2023; 14():1155182. PubMed ID: 37275857 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]